Tandon B N, Acharya S K, Tandon A
Pushpawati Singhania Research Institute for Liver and Digestive Diseases, New Delhi, India.
Gut. 1996;38 Suppl 2(Suppl 2):S56-9. doi: 10.1136/gut.38.suppl_2.s56.
The average estimated carrier rate of hepatitis B virus (HBV) in India is 4%, with a total pool of approximately 36 million carriers. Wide variations in social, economic, and health factors in different regions may explain variations in carrier rates from one part of the country to another. Professional blood donors constitute the major high risk group for HBV infection in India, with a hepatitis B surface antigen positivity rate of 14%. Blood transfusions represent the most important route of HBV transmission among adults. However, most of India's carrier pool is established in early childhood, predominantly by horizontal spread due to crowded living conditions and poor hygiene. Acute and subacute liver failure are common complications of viral hepatitis in India and HBV is reckoned to be the aetiological agent in 42% and 45% of adult cases, respectively. HBV is reported to be responsible for 70% of cases of chronic hepatitis and 80% of cases of cirrhosis of the liver. About 60% of patients with hepatocellular carcinoma are HBV marker positive. Small numbers of patients have been reported to be infected with the pre-core mutant virus but none with the S mutant. Coinfection with hepatitis C virus or hepatitis delta virus is comparatively uncommon. In conclusion, hepatitis B is a major public health problem in India and will continue to be until appropriate nationwide vaccination programmes and other control measures are established.
印度乙肝病毒(HBV)的估计平均携带率为4%,携带者总数约为3600万。不同地区社会、经济和健康因素的巨大差异可能解释了该国不同地区携带率的差异。职业献血者是印度HBV感染的主要高危人群,乙肝表面抗原阳性率为14%。输血是成年人中HBV传播的最重要途径。然而,印度大多数携带者群体是在儿童早期形成的,主要是由于生活条件拥挤和卫生状况差导致的水平传播。急性和亚急性肝衰竭是印度病毒性肝炎的常见并发症,HBV分别被认为是42%和45%的成人病例的病因。据报道,HBV导致70%的慢性肝炎病例和80%的肝硬化病例。约60%的肝细胞癌患者HBV标志物呈阳性。据报道,少数患者感染了前核心突变病毒,但没有感染S突变病毒。丙型肝炎病毒或丁型肝炎病毒合并感染相对少见。总之,乙肝是印度的一个主要公共卫生问题,在全国范围内建立适当的疫苗接种计划和其他控制措施之前,情况将持续如此。